Found: 1
Select item for more details and to access through your institution.
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 3, p. 252, doi. 10.1093/oncolo/oyac275
- By:
- Publication type:
- Article